Search Results - "Grand'maison, Francois"

Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis by Metz, Luanne M, Li, David K.B, Traboulsee, Anthony L, Duquette, Pierre, Eliasziw, Misha, Cerchiaro, Graziela, Greenfield, Jamie, Riddehough, Andrew, Yeung, Michael, Kremenchutzky, Marcelo, Vorobeychik, Galina, Freedman, Mark S, Bhan, Virender, Blevins, Gregg, Marriott, James J, Grand’Maison, Francois, Lee, Liesly, Thibault, Manon, Hill, Michael D, Yong, V. Wee

“…The risk of conversion from a first demyelinating event to MS was lower with minocycline than with placebo over 6 months but not over 24 months. Changes of…”
Get full text

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study by He, Anna, Merkel, Bernd, Brown, James William L, Zhovits Ryerson, Lana, Kister, Ilya, Malpas, Charles B, Sharmin, Sifat, Horakova, Dana, Kubala Havrdova, Eva, Spelman, Tim, Izquierdo, Guillermo, Eichau, Sara, Trojano, Maria, Lugaresi, Alessandra, Hupperts, Raymond, Sola, Patrizia, Ferraro, Diana, Lycke, Jan, Grand'Maison, Francois, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Larochelle, Catherine, Svenningsson, Anders, Petersen, Thor, Grammond, Pierre, Granella, Franco, Van Pesch, Vincent, Bergamaschi, Roberto, McGuigan, Christopher, Coles, Alasdair, Hillert, Jan, Piehl, Fredrik, Butzkueven, Helmut, Kalincik, Tomas

“…High-efficacy therapies in multiple sclerosis are traditionally used after unsuccessful treatment with first-line disease modifying therapies. We hypothesised…”
Get full text

Geographical variations in sex ratio trends over time in multiple sclerosis by Trojano, Maria

“…Notes how a female/male (F/M) ratio increase over time in multiple sclerosis (MS) patients has been demonstrated in many countries around the world, but…”
Get full text

Defining reliable disability outcomes in multiple sclerosis by Kalincik, Tomas, Cutter, Gary, Spelman, Tim, Jokubaitis, Vilija, Havrdova, Eva, Horakova, Dana, Trojano, Maria, Izquierdo, Guillermo, Girard, Marc, Duquette, Pierre, Prat, Alexandre, Lugaresi, Alessandra, Grand'Maison, Francois, Grammond, Pierre, Hupperts, Raymond, Oreja-Guevara, Celia, Boz, Cavit, Pucci, Eugenio, Bergamaschi, Roberto, Lechner-Scott, Jeannette, Alroughani, Raed, Van Pesch, Vincent, Iuliano, Gerardo, Fernandez-Bolaños, Ricardo, Ramo, Cristina, Terzi, Murat, Slee, Mark, Spitaleri, Daniele, Verheul, Freek, Cristiano, Edgardo, Sánchez-Menoyo, José Luis, Fiol, Marcela, Gray, Orla, Cabrera-Gomez, Jose Antonio, Barnett, Michael, Butzkueven, Helmut

“…Prevention of irreversible disability is currently the most important goal of disease modifying therapy for multiple sclerosis. The disability outcomes used in…”
Get full text

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis by Kalincik, Tomas, Jokubaitis, Vilija, Spelman, Tim, Horakova, Dana, Havrdova, Eva, Trojano, Maria, Lechner-Scott, Jeannette, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grammond, Pierre, Solaro, Claudio, Grand’Maison, Francois, Hupperts, Raymond, Prevost, Julie, Sola, Patrizia, Ferraro, Diana, Terzi, Murat, Butler, Ernest, Slee, Mark, Kermode, Allan, Fabis-Pedrini, Marzena, McCombe, Pamela, Barnett, Michael, Shaw, Cameron, Hodgkinson, Suzanne, Butzkueven, Helmut

“…Objective: This propensity score–matched analysis from MSBase compared the effectiveness of cladribine with interferon β, fingolimod or natalizumab. Methods:…”
Get full text

Fingolimod after natalizumab and the risk of short-term relapse by Jokubaitis, Vilija G, Li, Vivien, Kalincik, Tomas, Izquierdo, Guillermo, Hodgkinson, Suzanne, Alroughani, Raed, Lechner-Scott, Jeannette, Lugaresi, Alessandra, Duquette, Pierre, Girard, Marc, Barnett, Michael, GrandʼMaison, Francois, Trojano, Maria, Slee, Mark, Giuliani, Giorgio, Shaw, Cameron, Boz, Cavit, Spitaleri, Daniele L.A, Verheul, Freek, Haartsen, Jodi, Liew, Danny, Butzkueven, Helmut

“…OBJECTIVE:To determine early risk of relapse after switch from natalizumab to fingolimod; to compare the switch experience to that in patients switching from…”
Get full text

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis by Kalincik, Tomas, Horakova, Dana, Spelman, Tim, Jokubaitis, Vilija, Trojano, Maria, Lugaresi, Alessandra, Izquierdo, Guillermo, Rozsa, Csilla, Grammond, Pierre, Alroughani, Raed, Duquette, Pierre, Girard, Marc, Pucci, Eugenio, Lechner-Scott, Jeannette, Slee, Mark, Fernandez-Bolanos, Ricardo, Grand'Maison, Francois, Hupperts, Raymond, Verheul, Freek, Hodgkinson, Suzanne, Oreja-Guevara, Celia, Spitaleri, Daniele, Barnett, Michael, Terzi, Murat, Bergamaschi, Roberto, McCombe, Pamela, Sanchez-Menoyo, Jose, Simo, Magdolna, Csepany, Tunde, Rum, Gabor, Boz, Cavit, Havrdova, Eva, Butzkueven, Helmut

“…Objective In patients suffering multiple sclerosis activity despite treatment with interferon β or glatiramer acetate, clinicians often switch therapy to…”
Get full text

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS by Ribbons, Karen Ann, McElduff, Patrick, Boz, Cavit, Trojano, Maria, Izquierdo, Guillermo, Duquette, Pierre, Girard, Marc, Grand'Maison, Francois, Hupperts, Raymond, Grammond, Pierre, Oreja-Guevara, Celia, Petersen, Thor, Bergamaschi, Roberto, Giuliani, Giorgio, Barnett, Michael, van Pesch, Vincent, Amato, Maria-Pia, Iuliano, Gerardo, Fiol, Marcela, Slee, Mark, Verheul, Freek, Cristiano, Edgardo, Fernandez-Bolanos, Ricardo, Saladino, Maria-Laura, Rio, Maria Edite, Cabrera-Gomez, Jose, Butzkueven, Helmut, van Munster, Erik, Den Braber-Moerland, Leontien, La Spitaleri, Daniele, Lugaresi, Alessandra, Shaygannejad, Vahid, Gray, Orla, Deri, Norma, Alroughani, Raed, Lechner-Scott, Jeannette

“…Multiple Sclerosis is more common in women than men and females have more relapses than men. In a large international cohort we have evaluated the effect of…”
Get full text

Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score by Kunchok, Amy, Lechner-Scott, Jeannette, Granella, Franco, Trojano, Maria, Alroughani, Raed, Sola, Patrizia, Ferraro, Diana, Lugaresi, Alessandra, Onofrj, Marco, Ozakbas, Serkan, Izquierdo, Guillermo, Grammond, Pierre, Luis Sanchez-Menoyo, Jose, Van Wijmeersch, Bart, Boz, Cavit, Pucci, Eugenio, McCombe, Pamela, Grand’Maison, Francois, Spitaleri, Daniele, Vucic, Steve, Hupperts, Raymond, Jokubaitis, Vilija, Sormani, Maria Pia, Butzkueven, Helmut, Kalincik, Tomas

“…Background: The magnetic resonance imaging in multiple sclerosis (MAGNIMS) score combines relapses and magnetic resonance imaging (MRI) lesions to predict…”
Get full text

Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study by Kister, Ilya, Spelman, Tim, Alroughani, Raed, Lechner-Scott, Jeannette, Duquette, Pierre, Grand'Maison, Francois, Slee, Mark, Lugaresi, Alessandra, Barnett, Michael, Grammond, Pierre, Iuliano, Gerardo, Hupperts, Raymond, Pucci, Eugenio, Trojano, Maria, Butzkueven, Helmut

“…BackgroundDiscontinuation of injectable disease-modifying therapy (DMT) for multiple sclerosis (MS) after a long period of relapse freedom is frequently…”
Get full text

Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation by Zhu, Chao, Kalincik, Tomas, Horakova, Dana, Zhou, Zhen, Buzzard, Katherine, Skibina, Olga, Alroughani, Raed, Izquierdo, Guillermo, Eichau, Sara, Kuhle, Jens, Patti, Francesco, Grand'Maison, Francois, Hodgkinson, Suzanne, Grammond, Pierre, Lechner-Scott, Jeannette, Butler, Ernest, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Macdonell, Richard A L, Weinstock-Guttman, Bianca, Ozakbas, Serkan, Slee, Mark, Sa, Maria Jose, Van Pesch, Vincent, Barnett, Michael, Van Wijmeersch, Bart, Gerlach, Oliver, Prevost, Julie, Terzi, Murat, Boz, Cavit, Laureys, Guy, Van Hijfte, Liesbeth, Kermode, Allan G, Garber, Justin, Yamout, Bassem, Khoury, Samia J, Merlo, Daniel, Monif, Mastura, Jokubaitis, Vilija, van der Walt, Anneke, Butzkueven, Helmut

“…Natalizumab cessation is associated with a risk of rebound disease activity. It is important to identify the optimal switch disease-modifying therapy strategy…”
Get more information

Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis by Roos, Izanne, Sharmin, Sifat, Malpas, Charles, Ozakbas, Serkan, Lechner-Scott, Jeannette, Hodgkinson, Suzanne, Alroughani, Raed, Eichau Madueño, Sara, Boz, Cavit, van der Walt, Anneke, Butzkueven, Helmut, Buzzard, Katherine, Skibina, Olga, Foschi, Matteo, Grand’Maison, Francois, John, Nevin, Grammond, Pierre, Terzi, Murat, Prévost, Julie, Barnett, Michael, Laureys, Guy, Van Hijfte, Liesbeth, Luis Sanchez-Menoyo, Jose, Blanco, Yolanda, Oh, Jiwon, McCombe, Pamela, Ramo Tello, Cristina, Soysal, Aysun, Prat, Alexandre, Duquette, Pierre, Yamout, Bassem I, Khoury, Samia, van Pesch, Vincent, Macdonell, Richard, José Sá, Maria, Slee, Mark, Kuhle, Jens, Maimone, Davide, Spitaleri, Daniele LA, Willekens, Barbara, Asmi, Abdallah Al, Tallantyre, Emma, Robertson, Neil P, Coles, Alasdair, L Brown, J William, Kalincik, Tomas

“…Background: Comparisons between cladribine and other potent immunotherapies for multiple sclerosis (MS) are lacking. Objectives: To compare the effectiveness…”
Get full text

Risk of relapse phenotype recurrence in multiple sclerosis by Kalincik, Tomas, Buzzard, Katherine, Jokubaitis, Vilija, Trojano, Maria, Duquette, Pierre, Izquierdo, Guillermo, Girard, Marc, Lugaresi, Alessandra, Grammond, Pierre, Grand’Maison, Francois, Oreja-Guevara, Celia, Boz, Cavit, Hupperts, Raymond, Petersen, Thor, Giuliani, Giorgio, Iuliano, Gerardo, Lechner-Scott, Jeannette, Barnett, Michael, Bergamaschi, Roberto, Van Pesch, Vincent, Amato, Maria Pia, van Munster, Erik, Fernandez-Bolanos, Ricardo, Verheul, Freek, Fiol, Marcela, Cristiano, Edgardo, Slee, Mark, Rio, Maria Edite, Spitaleri, Daniele, Alroughani, Raed, Gray, Orla, Saladino, Maria Laura, Flechter, Sholmo, Herbert, Joseph, Cabrera-Gomez, Jose Antonio, Vella, Norbert, Paine, Mark, Shaw, Cameron, Moore, Fraser, Vucic, Steve, Savino, Aldo, Singhal, Bhim, Petkovska-Boskova, Tatjana, Parratt, John, Sirbu, Carmen-Adella, Rozsa, Csilla, Liew, Danny, Butzkueven, Helmut

“…Objectives: The aim was to analyse risk of relapse phenotype recurrence in multiple sclerosis and to characterise the effect of demographic and clinical…”
Get full text

Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a by Bovis, Francesca, Kalincik, Tomas, Lublin, Fred, Cutter, Gary, Malpas, Charles, Horakova, Dana, Havrdova, Eva Kubala, Trojano, Maria, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Onofrj, Marco, Lugaresi, Alessandra, Izquierdo, Guillermo, Eichau, Sara, Patti, Francesco, Terzi, Murat, Grammond, Pierre, Bergamaschi, Roberto, Sola, Patrizia, Ferraro, Diana, Ozakbas, Serkan, Iuliano, Gerardo, Boz, Cavit, Hupperts, Raymond, Grand'Maison, Francois, Oreja-Guevara, Celia, van Pesch, Vincent, Cartechini, Elisabetta, Petersen, Thor, Altintas, Ayse, Soysal, Aysun, Ramo-Tello, Cristina, McCombe, Pamela, Turkoglu, Recai, Butzkueven, Helmut, Wolinsky, Jerry S., Solaro, Claudio, Sormani, Maria Pia

“…OBJECTIVETo compare the effectiveness of glatiramer acetate (GA) vs intra-muscular Interferon beta-1a (IFNbeta-1a)), we applied a previously published…”
Get full text

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis by Signori, Alessio, Izquierdo, Guillermo, Lugaresi, Alessandra, Hupperts, Raymond, Grand’Maison, Francois, Sola, Patrizia, Horakova, Dana, Havrdova, Eva, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Boz, Cavit, Grammond, Pierre, Terzi, Murat, Singhal, Bhim, Alroughani, Raed, Petersen, Thor, Ramo, Cristina, Oreja-Guevara, Celia, Spitaleri, Daniele, Shaygannejad, Vahid, Butzkueven, Helmut, Kalincik, Tomas, Jokubaitis, Vilija, Slee, Mark, Fernandez Bolaños, Ricardo, Sanchez-Menoyo, Jose Luis, Pucci, Eugenio, Granella, Franco, Lechner-Scott, Jeannette, Iuliano, Gerardo, Hughes, Stella, Bergamaschi, Roberto, Taylor, Bruce, Verheul, Freek, Edite Rio, Maria, Amato, Maria Pia, Sajedi, Seyed Aidin, Majdinasab, Nastaran, Van Pesch, Vincent, Sormani, Maria Pia, Trojano, Maria

“…Background: Several natural history studies on primary progressive multiple sclerosis (PPMS) patients detected a consistent heterogeneity in the rate of…”
Get full text

Silent lesions on MRI imaging – Shifting goal posts for treatment decisions in multiple sclerosis by Min, Myintzu, Spelman, Tim, Lugaresi, Alessandra, Boz, Cavit, Spitaleri, Daniele LA, Pucci, Eugenio, Grand’Maison, Francois, Granella, Franco, Izquierdo, Guillermo, Butzkueven, Helmut, Sanchez-Menoyo, Jose Luis, Barnett, Michael, Girard, Marc, Trojano, Maria, Grammond, Pierre, Duquette, Pierre, Sola, Patrizia, Alroughani, Raed, Hupperts, Raymond, Vucic, Steve, Kalincik, Tomas, Van pesch, Vincent, Lechner-Scott, Jeannette

“…Background: The current best practice suggests yearly magnetic resonance imaging (MRI) to monitor treatment response in multiple sclerosis (MS) patients…”
Get full text

Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS by Kalincik, Tomas, Kister, Ilya, Bacon, Tamar E, Malpas, Charles B, Sharmin, Sifat, Horakova, Dana, Kubala-Havrdova, Eva, Patti, Francesco, Izquierdo, Guillermo, Eichau, Sara, Ozakbas, Serkan, Onofrj, Marco, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Alroughani, Raed, Terzi, Murat, Boz, Cavit, Grand’Maison, Francois, Bergamaschi, Roberto, Gerlach, Oliver, Sa, Maria J, Kappos, Ludwig, Cartechini, Elisabetta, Lechner-Scott, Jeannette, van Pesch, Vincent, Shaygannejad, Vahid, Granella, Franco, Spitaleri, Daniele, Iuliano, Gerardo, Maimone, Davide, Prevost, Julie, Soysal, Aysun, Turkoglu, Recai, Ampapa, Radek, Butzkueven, Helmut, Cutter, Gary

“…Background: The MSBase prediction model of treatment response leverages multiple demographic and clinical characteristics to estimate hazards of relapses,…”
Get full text

Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice by Spelman, Tim, Meyniel, Claire, Rojas, Juan Ignacio, Lugaresi, Alessandra, Izquierdo, Guillermo, Grand’Maison, Francois, Boz, Cavit, Alroughani, Raed, Havrdova, Eva, Horakova, Dana, Iuliano, Gerardo, Duquette, Pierre, Terzi, Murat, Grammond, Pierre, Hupperts, Raymond, Lechner-Scott, Jeannette, Oreja-Guevara, Celia, Pucci, Eugenio, Verheul, Freek, Fiol, Marcela, Van Pesch, Vincent, Cristiano, Edgardo, Petersen, Thor, Moore, Fraser, Kalincik, Tomas, Jokubaitis, Vilija, Trojano, Maria, Butzkueven, Helmut

“…Background: Characteristics at clinically isolated syndrome (CIS) examination assist in identification of patient at highest risk of early second attack and…”
Get full text

Contribution of different relapse phenotypes to disability in multiple sclerosis by Stewart, Tamasine, Spelman, Tim, Havrdova, Eva, Horakova, Dana, Trojano, Maria, Izquierdo, Guillermo, Duquette, Pierre, Girard, Marc, Prat, Alexandre, Lugaresi, Alessandra, Grand’Maison, Francois, Grammond, Pierre, Sola, Patrizia, Shaygannejad, Vahid, Hupperts, Raymond, Alroughani, Raed, Oreja-Guevara, Celia, Pucci, Eugenio, Boz, Cavit, Lechner-Scott, Jeannette, Bergamaschi, Roberto, Van Pesch, Vincent, Iuliano, Gerardo, Ramo, Cristina, Taylor, Bruce, Slee, Mark, Spitaleri, Daniele, Granella, Franco, Verheul, Freek, McCombe, Pamela, Hodgkinson, Suzanne, Amato, Maria Pia, Vucic, Steve, Gray, Orla, Cristiano, Edgardo, Barnett, Michael, Sanchez Menoyo, Jose Luis, van Munster, Erik, Saladino, Maria Laura, Olascoaga, Javier, Prevost, Julie, Deri, Norma, Shaw, Cameron, Singhal, Bhim, Moore, Fraser, Rozsa, Csilla, Shuey, Neil, Skibina, Olga, Kister, Ilya, Petkovska-Boskova, Tatjana, Ampapa, Radek, Kermode, Allan, Butzkueven, Helmut, Jokubaitis, Vilija, Kalincik, Tomas

“…Objective: This study evaluated the effect of relapse phenotype on disability accumulation in multiple sclerosis. Methods: Analysis of prospectively collected…”
Get full text

Identification of Therapeutic Lag in Multiple Sclerosis (1787) by Roos, Izanne, Leray, Emmanuelle, Frascoli, Federico, Casey, Romain, Horakova, Dana, Havrdova, Eva, Trojano, Maria, Ayuso, Guillermo Izquierdo, Madueno, Sara Eichau, Patti, Francesco, Onofrj, Marco, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Ozakbas, Serkan, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Bergamaschi, Roberto, Boz, Cavit, Cartechini, Elisabetta, Sa, Maria Jose, Terzi, Murat, Alroughani, Raed, Grand’Maison, Francois, Granella, Franco, Iuliano, Gerardo, Hupperts, Raymond, Lechner-Scott, Jeannette, Spitaleri, Daniele Litterio A., Van Pesch, Vincent, Soysal, Aysun, Prevost, Julie, Morales, Eduardo Aguera, Urtaza, Francisco Javier Olascoaga, Turkoglu, Recai, Sidhom, Youssef, Gouider, Riadh, Van Wijmeersch, Bart, Butzkueven, Helmut, Malpas, Charles, Vukusic, Sandra, Kalincik, Tomas

“…Abstract only…”
Get full text